AI Networking Cookbook: Practical recipes for AI-assisted network automation and development
TL;DR
This review aims to evaluate the current and emerging treatment paradigms, including environmental avoidance, pharmacotherapy, surgical interventions, monoclonal antibodies, and immunotherapy options for allergic rhinitis.
Allergic rhinitis (AR) is one of the most common chronic disorders in childhood and is associated with impaired sleep, school performance and quality of life as well as bronchial asthma. Contemporary management includes family education, reduction of clinically relevant allergen and irritant exposure, pharmacotherapy,...
The use of omalizumab, in combination with AIT, has proven to be an effective option in treating patients with allergic asthma and during food desensitization, particularly in the dose escalation phase when adverse reactions are more common.
Allergic rhinitis (AR) is a common chronic inflammatory disorder of the upper respiratory tract resulting from an immunologically mediated response to inhaled allergens. Sneezing, nasal itching, watery rhinorrhoea and nasal obstruction constitute its characteristic clinical manifestations, frequently accompanied by ocu...
The prevalence of allergic diseases in children has been steadily increasing, representing a significant diagnostic and therapeutic challenge for primary care physicians and paediatricians. The most common allergic conditions in childhood include allergic rhinitis, allergic conjunctivitis, and asthma. These diseases ca...
Allergic disorders, particularly allergic rhinitis and urticaria, are prevalent immune mediated conditions that can substantially affect patients’ quality of life. Histamine plays a central role in allergic responses, primarily through activation of histamine H₁ receptors, making H₁-receptor antagonists an important co...
Allergic rhinitis is an inflammatory disorder of the nasal mucosa induced by allergen exposure, triggering an immunoglobulin E-mediated response. It is an extremely common condition, where the prevalence estimated that 20%–30% of the population exhibiting symptoms either as seasonal or perennial allergic rhinitis. Cl...
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.